日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Effect of frailty on treatment, hospitalisation and death in patients with chronic heart failure

虚弱症对慢性心力衰竭患者的治疗、住院和死亡的影响

Sze, S; Pellicori, P; Zhang, J; Weston, J; Squire, I B; Clark, A L

Prognostic significance of anaemia in patients with heart failure with preserved and reduced ejection fraction: results from the MAGGIC individual patient data meta-analysis

贫血对射血分数保留和降低的心力衰竭患者的预后意义:MAGGIC个体患者数据荟萃分析的结果

Berry, C; Poppe, K K; Gamble, G D; Earle, N J; Ezekowitz, J A; Squire, I B; McMurray, J J V; McAlister, F A; Komajda, M; Swedberg, K; Maggioni, A P; Ahmed, A; Whalley, G A; Doughty, R N; Tarantini, L

Remote ischaemic conditioning and remodelling following myocardial infarction: current evidence and future perspectives

心肌梗死后远程缺血预适应和重塑:现有证据和未来展望

Vanezis, A P; Rodrigo, G C; Squire, I B; Samani, N J

Circulating stromelysin-1 (MMP-3): a novel predictor of LV dysfunction, remodelling and all-cause mortality after acute myocardial infarction.

循环基质溶解素-1 (MMP-3):急性心肌梗死后左心室功能障碍、重塑和全因死亡率的新预测因子

Kelly D, Khan S, Cockerill G, Ng L L, Thompson M, Samani N J, Squire I B

The rational use of beta-adrenoceptor blockers in the treatment of heart failure. The changing face of an old therapy

合理应用β-肾上腺素受体阻滞剂治疗心力衰竭:一种古老疗法的变革

Squire, I B; Barnett, D B

Haemodynamic response and pharmacokinetics after the first dose of quinapril in patients with congestive heart failure

充血性心力衰竭患者首次服用喹那普利后的血流动力学反应和药代动力学

Squire, I B; Macfadyen, R J; Lees, K R; Hillis, W S; Reid, J L

Immunosuppressive treatment in stroke and renal failure

中风和肾衰竭的免疫抑制治疗

Squire, I B; Grosset, D G; Lees, K R

The experiences of an acute stroke unit--implications for multicentre acute stroke trials

急性卒中单元的经验——对多中心急性卒中试验的启示

Morris, A D; Grosset, D G; Squire, I B; Lees, K R; Bone, I; Reid, J L